These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37522494)

  • 41. Treatment of melasma and the use of intense pulsed light: a review.
    Zaleski L; Fabi S; Goldman MP
    J Drugs Dermatol; 2012 Nov; 11(11):1316-20. PubMed ID: 23135081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How hormones may modulate human skin pigmentation in melasma: An in vitro perspective.
    Cario M
    Exp Dermatol; 2019 Jun; 28(6):709-718. PubMed ID: 30883945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation method for blue light (456 nm) protection of skin.
    Jo HL; Jung Y; Suh BF; Cho E; Kim K; Kim E
    J Cosmet Dermatol; 2020 Sep; 19(9):2438-2443. PubMed ID: 32459880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study.
    Yousefi A; Khani Khoozani Z; Zakerzadeh Forooshani S; Omrani N; Moini AM; Eskandari Y
    Dermatol Surg; 2014 Jan; 40(1):33-7. PubMed ID: 24237751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pigmentation control in pregnancy-induced melasma: Clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum.
    Makino ET; Jiang LI; Stephens TJ; Mikati M; Mehta RC
    J Cosmet Dermatol; 2022 Nov; 21(11):5739-5746. PubMed ID: 35708506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A clinical, dermoscopic, histopathological and immunohistochemical study of melasma and facial pigmentary demarcation lines in the skin of color.
    Khunger N; Kandhari R; Singh A; Ramesh V
    Dermatol Ther; 2020 Nov; 33(6):e14515. PubMed ID: 33169501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.
    Cantelli M; Ferrillo M; Granger C; Fabbrocini G
    J Cosmet Dermatol; 2022 Apr; 21(4):1523-1532. PubMed ID: 34087055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
    Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
    J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photoaging Reversibility in Asian Patients With Melasma Treated Using Picosecond Lasers With a Diffractive Lens Array: A 1-Year Prospective Observational Cohort Study.
    Lin ET; Chiang HM; Lin BS; Huang YH; Chang CC
    Dermatol Surg; 2021 Jan; 47(1):e10-e14. PubMed ID: 32271179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.
    Manuskiatti W; Yan C; Tantrapornpong P; Cembrano KAG; Techapichetvanich T; Wanitphakdeedecha R
    Lasers Surg Med; 2021 Jan; 53(1):95-103. PubMed ID: 32865858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
    Garg S; Vashisht KR; Makadia S
    J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
    Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized clinical trial of facial acupuncture with or without body acupuncture for treatment of melasma.
    Rerksuppaphol L; Charoenpong T; Rerksuppaphol S
    Complement Ther Clin Pract; 2016 Feb; 22():1-7. PubMed ID: 26850796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blue light protection factor: a method to assess the protective efficacy of cosmetics against blue light-induced skin damage in the Chinese population.
    Zhang R; Pu W; Zhang X; Di Y; Xu J; Zhu M; Tan Y; Liu W; Krutmann J; Wang J; Ma Y
    Photochem Photobiol Sci; 2024 Apr; 23(4):711-718. PubMed ID: 38430370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
    Yue B; Yang Q; Xu J; Lu Z
    Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new visible light absorbing organic filter offers superior protection against pigmentation by wavelengths at the UVR-visible boundary region.
    Lawrence KP; Sarkany RPE; Acker S; Herzog B; Young AR
    J Photochem Photobiol B; 2022 Feb; 227():112372. PubMed ID: 34954519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients.
    Lee HI; Lim YY; Kim BJ; Kim MN; Min HJ; Hwang JH; Song KY
    Dermatol Surg; 2010 Jun; 36(6):885-93. PubMed ID: 20482724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.